Relationship between IDH1/2 and TERT promoter mutation and the prognosis of human glioma patients.

Liu, Xipeng; Liu, Ming; Cao, Bing; Qiao, Jianxin; Zhang, Xiufeng

Liu, Xipeng; Liu, Ming; Cao, Bing; Qiao, Jianxin; Zhang, Xiufeng.

Afiliação

Liu X; Xiping Liu, Department of Neurosurgery, The First Affiliated Hospital of Hebei North University Zhangjiakou 075000, Hebei Province, P.R. China.
Liu M; Ming Liu, Department of Neurosurgery, The First Affiliated Hospital of Hebei North University Zhangjiakou 075000, Hebei Province, P.R. China.
Cao B; Bing Caom, Department of Neurosurgery, The First Affiliated Hospital of Hebei North University Zhangjiakou 075000, Hebei Province, P.R. China.
Qiao J; Jianxin Qiao, Department of Neurosurgery, The First Affiliated Hospital of Hebei North University Zhangjiakou 075000, Hebei Province, P.R. China.
Zhang X; Xiufeng Zhang, Department of Neurosurgery, The First Affiliated Hospital of Hebei North University Zhangjiakou 075000, Hebei Province, P.R. China.

Pak J Med Sci ; 39(3): 843-847, 2023.

Article em En | MEDLINE | ID: mdl-37250582

Palavras-chave

Human glioma; Isocitrate dehydrogenase; Promoter region mutation; Telomerase reverse transcriptase

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pak J Med Sci Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google